Immunotherapy in Omental Cancer: Emerging Treatments and Clinical Trials
Received Date: Feb 01, 2024 / Published Date: Feb 29, 2024
Abstract
Omentum cancer, also known as omental cancer, refers to cancer that originates in the omentum, a fold of the peritoneum (the membrane lining the abdominal cavity) that hangs down from the stomach and covers the intestines. The omentum contains fat and is rich in blood vessels, lymphatics, and immune cells. Omentum cancer can either be primary, meaning it starts in the omentum itself, or secondary (metastatic), meaning it spreads to the omentum from another primary cancer site, such as the ovaries, colon, stomach, or pancreas. Symptoms of omentum cancer may include abdominal pain, bloating, nausea, vomiting, weight loss, and changes in bowel habits. Treatment typically involves a combination of surgery, chemotherapy, and radiation therapy, depending on the type and stage of the cancer. Early detection and treatment can improve outcomes for individuals with omentum cancer
Citation: Adam I (2024) Immunotherapy in Omental Cancer: Emerging Treatmentsand Clinical Trials. Current Trends Gynecol Oncol, 9: 200.
Copyright: © 2024 Adam I. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 235
- [From(publication date): 0-2024 - Feb 28, 2025]
- Breakdown by view type
- HTML page views: 189
- PDF downloads: 46